oral insulin (Biota/CSIRO)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameoral insulin (Biota/CSIRO)
Drug Alias Namediabetes therapy (Biota/CSIRO)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin receptor agonistsInsulin ligand
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiota Holdings Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A